Cortesi, P. A., Paolicelli, D., Capobianco, M., Cozzolino, P., & Mantovani, L. G. (2019). The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis. Farmeconomia. Health Economics and Therapeutic Pathways, 20(1). https://doi.org/10.7175/fe.v20i1.1435